Shunmugavelu, M and Shah, T and kumar, G V and Sudagani, J and Arivazhahan, A and Khader, J and Mohan, V (2019) Myths and Facts About Glimepiride. Journal of the Association of Physicians, 67 . p. 24.
![[img]](/style/images/fileicons/application_pdf.png)
| PDF 209Kb |
Abstract
Glimepiride is either used as monotherapy or in combination with metformin or insulin for effective control of hyperglycemia in people with type 2 diabetes mellitus. In spite of its effective glucose-lowering potential, similar to other sulfonylureas, glimepiride has been associated with several myths like cardiovascular risk, hypoglycemic effects, weight gain, beta-cell failure, risk in special populations of diabetic patients, and effects of metabolites. Here, we will discuss the myths and facts associated with glimepiride and its safety and concern issues
| Item Type: | Article |
|---|---|
| Official URL/DOI: | http://www.japi.org/december_2019_spl/contents.htm... |
| Uncontrolled Keywords: | Type 2 Diabetes |
| Subjects: | Diabetes |
| Divisions: | Department of Diabetology |
| ID Code: | 1177 |
| Deposited By: | surendar radha |
| Deposited On: | 05 Feb 2020 14:18 |
| Last Modified: | 05 Feb 2020 14:18 |
Repository Staff Only: item control page
